PER 0.00% 7.8¢ percheron therapeutics limited

per-chart, page-609

  1. 13,134 Posts.
    lightbulb Created with Sketch. 1376
    Many think on here that I exaggerate my sp and MC
    predictions:
    Let me explain

    A phase 2b molecule is worth in excess of $285 million


    That’s around 35c per share

    So IF our Tox and DMD is successful( ( meaning we replicate our end points PUL 2.0)

    We move to a Phase 3
    A molecule in P3 is worth $1248 million

    The interesting thing here is .. that if the DMD results are better than expected PER w
    ill go to the FDA .. for going into commercialisation $$

    Once we get the green light from the FDA
    PER has stated we could have a market of $1 billion US per annum and that’s only in DMD..








    nhttps://hotcopper.com.au/data/attachments/6130/6130180-dcc797ca513a0a89b70fe9f8905b46c8.jpg
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.8¢
Change
0.000(0.00%)
Mkt cap ! $70.32M
Open High Low Value Volume
7.8¢ 7.9¢ 7.8¢ $5.891K 75.05K

Buyers (Bids)

No. Vol. Price($)
1 6454 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 19621 2
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.